|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 183.28 USD | -0.49% |
|
-2.71% | +22.01% |
| Capitalization | 20.49B 17.57B 16.43B 15.35B 28.57B 1,840B 30.95B 193B 74.38B 870B 76.9B 75.26B 3,171B | P/E ratio 2025 * |
21.4x | P/E ratio 2026 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise value | 25.85B 22.17B 20.73B 19.36B 36.05B 2,322B 39.05B 243B 93.86B 1,097B 97.03B 94.96B 4,001B | EV / Sales 2025 * |
2.35x | EV / Sales 2026 * | 2.25x |
| Free-Float |
67.83% | Yield 2025 * |
1.67% | Yield 2026 * | 1.7% |
Last Transcript: Quest Diagnostics Incorporated
| 1 day | +0.06% | ||
| 1 week | -2.90% | ||
| Current month | -2.64% | ||
| 1 month | +3.45% | ||
| 3 months | +2.26% | ||
| 6 months | +5.97% | ||
| Current year | +22.09% |
| 1 week | 182.21 |  | 189.38 |
| 1 month | 175.67 | | 193.76 |
| Current year | 148.7 | | 197.55 |
| 1 year | 148.7 | | 197.55 |
| 3 years | 119.59 | | 197.55 |
| 5 years | 113.36 | | 197.55 |
| 10 years | 59.66 | | 197.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 62 | 2022-02-02 |
Sam Samad
DFI | Director of Finance/CFO | 55 | 2022-07-10 |
Kristin Wallace
CMP | Compliance Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Pfeiffer
BRD | Director/Board Member | 75 | 2004-11-30 |
Timothy Ring
BRD | Director/Board Member | 67 | 2011-12-06 |
James Davis
CHM | Chairman | 62 | 2023-03-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 14.84% | 303 M€ | -21.27% | - |
| 2.17% | 2 M€ | -.--% | - |
| 2.05% | 5 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.08% | -2.90% | +14.94% | +22.41% | 20.49B | |
| -0.31% | -5.26% | +50.47% | +104.02% | 111B | |
| -0.72% | -3.89% | +32.21% | -25.18% | 97.43B | |
| +0.32% | +1.96% | +42.07% | +81.29% | 31.44B | |
| +2.20% | +3.89% | -11.74% | +8.65% | 23.43B | |
| -0.64% | -2.53% | +10.15% | +8.24% | 21.68B | |
| -0.84% | +0.88% | +72.75% | +61.26% | 19.75B | |
| -0.25% | -2.43% | +49.91% | +368.51% | 18.64B | |
| -0.29% | -5.57% | +15.80% | +78.27% | 14.41B | |
| +0.61% | -2.21% | -11.75% | +30.26% | 13.41B | |
| Average | +0.05% | -1.70% | +26.48% | +73.77% | 37.2B | |
| Weighted average by Cap. | -0.06% | -2.82% | +34.32% | +59.50% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.98B 9.42B 8.81B 8.23B 15.32B 987B 16.59B 103B 39.87B 466B 41.22B 40.35B 1,700B | 11.38B 9.76B 9.13B 8.53B 15.87B 1,022B 17.19B 107B 41.32B 483B 42.72B 41.81B 1,762B |
| Net income | 982M 842M 787M 735M 1.37B 88.21B 1.48B 9.24B 3.56B 41.68B 3.69B 3.61B 152B | 1.05B 901M 843M 787M 1.47B 94.4B 1.59B 9.89B 3.82B 44.6B 3.94B 3.86B 163B |
| Net Debt | 5.36B 4.6B 4.3B 4.02B 7.48B 482B 8.1B 50.47B 19.48B 228B 20.13B 19.71B 830B | 5.09B 4.37B 4.08B 3.81B 7.1B 458B 7.69B 47.92B 18.49B 216B 19.12B 18.71B 788B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 183.82 $ | -0.20% | 55,750 |
| 25-12-04 | 184.18 $ | +0.86% | 1,044,861 |
| 25-12-03 | 182.61 $ | +0.03% | 1,057,340 |
| 25-12-02 | 182.55 $ | -0.66% | 1,177,547 |
| 25-12-01 | 183.77 $ | -2.86% | 1,175,803 |
Delayed Quote Nyse, December 05, 2025 at 09:30 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DGX Stock
Select your edition
All financial news and data tailored to specific country editions
